At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines have been placed on mute to prevent any background noise. After the ...
NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...
After-hours stock movements include GameStop (GME), Twilio (TWLO), and DexCom (DXCM). To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend  ...
My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines ...
DexCom Q4 revenue rose 8% YoY to $1.11 billion, beating estimates of $1.104 billion. DexCom reaffirms 2025 revenue guidance at $4.60 billion vs. consensus of $4.61 billion. Get real-time earnings ...
Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...
DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue ...
Financial giants have made a conspicuous bearish move on DexCom. Our analysis of options history for DexCom (NASDAQ:DXCM) revealed 12 unusual trades. Delving into the details, we found 33% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback